2023 AdvaMed CEO Summit

After nearly three decades in federal service as a US congressman and senator, Richard Burr is widely known as one of the foremost government authorities in healthcare and life sciences policy. Since his election to Congress in 1994 and through his tenure as Ranking Member of the Senate Committee on Health, Education, Labor and Pensions (HELP), Senator Burr has led many of the most transformative government initiatives in the healthcare and life sciences fields. His legislative accomplishments include the 1997 FDA Modernization Act, the Pandemic All Hazards Preparedness Act, which created the Biomedical Advanced Research and Development Authority (BARDA) and was critical in the rapid development of the COVID-19 pandemic vaccine, the PREVENT Pandemics Act, and the creation of ARPA-H, which established the Advanced Research Projects Authority for Health (ARPA-H) within the National Institutes of Health. For decades, Senator Burr has helped shape nearly every medical agency, instrumentality and operation of the US Federal Government.

Richard is a former Chairman and senior member of the Senate’s Select Committee on Intelligence, and he served as an influential member of the Finance Committee for twelve years. As a member of the Intelligence Committee, and ultimately its Chairman, Richard helped drive the shift of the intelligence community towards current threats and advised banking, manufacturing and academic sectors of the threats posed by malign actors around the world. As Chairman, he led the committee to act as the de facto technology committee, informing others in the Senate about threats and opportunities of 5G modernization, supply chain vulnerabilities related to semiconductors and other emerging technologies.

During his five terms in the House of Representatives and three terms in the Senate, Richard also led initiatives in education, civil rights and conservation policy. He contributed to drafting the Bipartisan Student Loan Certainty Act, which dramatically reduced interest rates for students who have federal student loans, and he was the principal drafter of the latest Child Care Development Block Grant reauthorization. Richard spearheaded the passage of the Stephen Beck, Jr. Achieving a Better Life Experience (ABLE) Act, which allowed for individuals with disabilities to save money in their own name without losing critical benefits, and he worked to reauthorize the Emmett Till Unsolved Civil Rights Crimes Reauthorization Act. Richard also led a bipartisan group of senators in passing the Great American Outdoors Act, landmark conservation legislation that fully and permanently funds the Land and Water Conservation Fund (LWCF).

In over 30 years in reimbursement, Jo has held various roles in provider, medical device and health plan organizations. As a consultant, she works to accelerate adoption of innovative technologies by integrating coding, and payment policy initiatives including applications for HCPCS and ICD-10 coding. Jo also combines strategic advocacy strategies to understand and impact the payer coverage landscape. Jo also serves as the CPT and RUC staff for the American Society of General Surgeons.

DeChane Dorsey is executive director of AdvaMed Accel, the division within AdvaMed dedicated to the needs of smaller medical technology manufacturers. The vision of AdvaMed Accel is to be the leader in advancing medical technology by bolstering the industry’s emerging and early-growth enterprises – the drivers of disruptive innovation, job creation, and economic expansion. The division is committed to ensuring the voice of small pioneering and entrepreneurial companies is always heard by policymakers.

DeChane is also team lead on AdvaMed’s heath equity workstream, spearheading the creation and execution of AdvaMed’s Principles on Health Equity. Previously, as AdvaMed’s Vice President of Payment and Health Care Delivery Policy, DeChane provided analysis and guidance to association members on Medicare payment, coding, and coverage issues; and developed the association’s policy positions for improved payment and coding infrastructure.

Before joining AdvaMed, DeChane served as Director of Health Policy for the American Academy of Ophthalmology and as Senior Counsel in the Office of Counsel to the Inspector General within the U.S. Department of Health and Human Services. DeChane started her career as a Westwood Fellow at the Neighborhood Legal Services Program in Washington, D.C.

DeChane received a Bachelor of Arts in Political Science from Syracuse University and a Juris Doctor from Georgetown University Law Center.

Tim Dugan has more than 30 years of experience building market-leading companies in the healthcare industry. He has been actively involved in the strategic growth and development of companies across all major healthcare sectors and leads the management of Water Street’s family of companies. Prior to establishing Water Street, he was a founding partner of One Equity Partners, the private equity arm of JPMorgan Chase. Tim is a member of the board of directors of The Advanced Medical Technology Association (AdvaMed), a trade organization that is spearheading the effort to advance medical technology to achieve healthier lives and economies around the world. On behalf of Water Street, he currently serves on the board of directors of ALCOR Scientific, Long Grove Pharmaceuticals, Pathnostics and Viant. Tim is involved with a number of civic organizations and serves on the boards of Providence Englewood Charter School and the Chicago Botanic Garden. Tim received dual bachelor’s degrees in electrical engineering and economics from Stanford University. He earned a master’s degree in business administration from the University of Chicago Graduate School of Business.

Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience identifying opportunities for growth and delivering success in small startup to multi-billion-dollar environments. She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-potential leaders. In addition to holding the CEO role at Vibrato, Ms. Elstad is a Board member of AdvaMed Accel, the world’s largest Medtech trade association. Prior to Vibrato, Ms. Elstad was CEO of Impleo Medical, a medtech company recognized as one of the world’s Top 50 most innovative startups in 2018; founder of Elstad Medical, advisory firm to medtech CEOs and boards; EVP of business development at Intelect Medical (acquired by Boston Scientific); and led business development efforts at Medtronic, Inc. as well as coordinated strategic planning, performed market analyses for new therapies, and led cross-functional committees.

Juliana started her career as a management consultant with McKinsey & Company and a financial auditor with Arthur Andersen. She received her MBA from the Wharton Business School, University of Pennsylvania, and her Masters in Economics from the Moscow State Institute of International Relations. She is married with two kids and lives in Irvine, CA.

The COVID-19 pandemic significantly impacted financial security, health, and social justice—Roger leads the discussion on how organizations can minimize the financial scars of the pandemic and how financial well-being is changing for the future.

Roger W. Ferguson, Jr., is the former President and Chief Executive Officer of TIAA (2008-2021), the leading provider of retirement services in the academic, research, medical and cultural fields, and a Fortune 100 financial services organization.

Roger is the former Vice Chairman of the Board of Governors of the U.S. Federal Reserve System. He represented the Federal Reserve on several international policy groups and served on key Federal Reserve System committees, including Payment System Oversight, Reserve Bank Operations, and Supervision and Regulation. As the only Governor in Washington, D.C., on 9/11, Roger led the Fed’s initial response to the terrorist attacks, taking actions that kept the U.S. financial system functioning while reassuring the global financial community that the U.S. economy would not be paralyzed.

Prior to joining TIAA in April 2008, he was head of financial services for Swiss Re, Chairman of Swiss Re America Holding Corporation, and a member of the company’s executive committee. From 1984 to 1997, Roger was an Associate and Partner at McKinsey & Company. He began his career as an attorney at the New York City office of Davis Polk & Wardwell. He is a member of the Smithsonian Institution’s Board of Regents and serves on the boards of Alphabet, Inc.; General Mills, Inc.; and International Flavors & Fragrances, Inc. Roger is a fellow of the American Academy of Arts & Sciences and co-chairs its Commission on the Future of Undergraduate Education.

Roger serves on the boards of The Conference Board, the Institute for Advanced Study and Memorial Sloan Kettering Cancer Center. He is a fellow of the American Philosophical Society and a member of the Economic Club of New York, the Council on Foreign Relations, the Group of Thirty and the National Association for Business Economics.

Roger served on President Obama’s Council on Jobs and Competitiveness as well as its predecessor, the Economic Recovery Advisory Board, and he co-chaired the National Academy of Sciences’ Committee on the Long-Run Macro-Economic Effects of the Aging U.S. Population. Roger holds a B.A., J.D., and a Ph.D. in economics, all from Harvard University.

Jane Fraser is the Chief Executive Officer of Citi, a leading global bank, serving millions of consumers, businesses and institutions across nearly 160 countries and jurisdictions. She is the first female CEO in the firm’s history.

Jane has deep experience across Citi’s consumer and institutional businesses and, in many ways, she helped shape Citi into the company it is today. Before becoming CEO in February 2021, she was President of Citi and CEO of the Global Consumer Bank, responsible for all of Citi’s Consumer businesses, including Retail Banking and Wealth Management, Credit Cards, Mortgage and Operations and Technology in 19 markets. Before that, she was the Chief Executive Officer of Citigroup Latin America from 2015 to 2019. From 2013 to 2015, she was the Chief Executive Officer of the U.S. Consumer and Commercial Banking and CitiMortgage. From 2009 to 2013, Jane served as the Chief Executive Officer of Citi’s Global Private Bank. Prior, Jane was the Global Head of Strategy and Mergers & Acquisitions for Citi from 2007 to 2009. She joined Citi in 2004 in the Corporate and Investment Banking division.

Before joining Citi, Jane was a Partner at McKinsey & Company. She started her career at Goldman Sachs in the Mergers & Acquisitions department in London and then worked for Asesores Bursátiles in Madrid, Spain.

Jane serves as a Board Member for the Business Roundtable and the Council on Foreign Relations. She is Vice Chair for the Partnership for New York City and a member of Harvard Business School’s Board of Dean’s Advisors, the Stanford Global Advisory Board and the Economic Club of New York. Jane has an M.B.A. from Harvard Business School and an M.A. in economics from Cambridge University. She is married with two children.

Damar Hamlin is currently a starting safety for the Buffalo Bills. Before being drafted in 2021, he played at the University of Pittsburgh where he was a team captain and named second-team All-ACC during his final season. Off the field, Damar makes giving back to the community a priority by being involved in community football camps and charity sports games. He shows off his personality on social media, especially in his Buffalo-based wing review series, “Damar’s Wing Review.” He also owns his own clothing brand called Chasing Millions.

Damar started Chasing M’s Foundation to be used as a vehicle to give back to the people who helped him get to where he is today and lift up the next generation of youth. He started off with a toy drive that expanded into camps and back-to-school drives. Chasing M’s is a 501 (c) (3) non-profit organization dedicated to supporting the aspirations of youth and community members through sports, education, and enrichment opportunities.

Sheryl Jacobson leads US Deloitte Consulting’s Medtech practice and is the lead business partner for Deloitte’s largest global client relationship.

Sheryl came to Deloitte in 2013 through the acquisition of Monitor Group – a boutique strategy firm. And in her time both at Monitor and at Deloitte, Sheryl’s focus has been on helping clients see the future opportunities and risks and make the right strategic, operational and leadership choices to capitalize on those opportunities. Her work in recent years has particularly focused on the AI, data and digital driven transformation happening in the Medtech industry.

Over the course of her career, Sheryl has worked extensively overseas including time in Europe and most recently in Shanghai from 2012-2016. Over the course of that time, she held various leadership roles including leading Deloitte’s strategy and life science consulting practices for China and for Asia. Sheryl holds an AB from Dartmouth College and a MBA from Columbia Business School. She lives in Harlem with her husband, Mark, and son, Michael.

Justin Klein, MD, JD, is a co-founder and Managing Partner at Vensana Capital, a leading venture capital and growth equity firm dedicated to medtech innovation. Justin was previously a partner and leader of the medical technology investing practice at NEA, one of the largest and most active venture capital firms in the world.  Justin also worked at the Duke University Health System where his experience included roles in strategy, finance and operations as Duke built one of the nation’s first integrated healthcare delivery systems. Justin currently or previously served on the board of directors of Apella, Cartiva (acquired), ChromaCode, Cleerly, CV Ingenuity (acquired), Epix Therapeutics (acquired), FIRE1, GPB Scientific, Intact Vascular (acquired), Metavention, Personal Genome Diagnostics (acquired), PhaseBio Pharmaceuticals (IPO), Plexium, Relievant Medsystems, Senseonics (IPO), Topera (acquired), Ulthera (acquired), Vertiflex (acquired), Vesper Medical (acquired), and VytronUS (acquired).

Justin currently serves as a member of the Board of Directors of the Medical Device Manufacturers Association and that of AdvaMed Accel, where he is the Chair of its Medtech Investment Working Group.

Justin graduated with an AB in Economics, a BS in Biological Anthropology & Anatomy, and a Minor in Chemistry from Duke University.  He also concurrently earned his MD from the Duke University School of Medicine and his JD from Harvard Law School.

Michael “Mike” Mahoney is Chief Executive Officer of Boston Scientific Corporation and Chairman of the company’s Board of Directors. Boston Scientific is a global medical technology leader with approximately $11.9 billion in annual revenue and commercial representation in more than 115 countries. Under Mike’s leadership, Boston Scientific is delivering on its mission to transform lives through innovative medical solutions that improve the health of patients around the world. The company’s team of more than 41,000 global employees reaches over 30 million patients each year, providing a range of technologies and solutions that span cardiovascular interventions, structural heart, electrophysiology, endoscopy, neuromodulation and urology, and women’s health.

Since joining Boston Scientific, Mike has focused the company on addressing the needs of the evolving health care landscape by driving improvements to patient outcomes and increasing health care economic efficiency and access. Under his leadership, Boston Scientific has brought many transformational medical devices to market while creating significant value to its shareholders.

Mike’s career spans more than 25 years of success building market-leading medical device, capital equipment and health care IT businesses. Prior to Boston Scientific, he served as Worldwide Chairman of the Medical Devices and Diagnostics (MD&D) division of Johnson & Johnson.

Prior to joining Johnson & Johnson, Mike was President and Chief Executive Officer of Global Healthcare Exchange (GHX). For the first 12 years of his career, Mike advanced through a series of leadership roles at General Electric Medical Systems, including General Manager of the company’s Healthcare Information Technology business.
Mike serves on the Board of Directors of Baxter International, the Board of Boys & Girls Club of Boston and as the chair of the Board of Governors of Boston College CEO Club. He earned his B.B.A. in Finance from University of Iowa and his M.B.A. from Wake Forest University. He is married and has three children.

As Executive Vice President and Worldwide Chairman of Medtech at Johnson & Johnson, Ashley McEvoy is transforming the future of healthcare. Under Ashley’s leadership, the $27B organization of almost 60,000 employees, nearly half of the Fortune #36 company’s employee base, drives innovation to save lives and ignite all that’s possible in every human, everywhere.

With a presence in almost every operating room in the world and more than 75 million procedures each year, Johnson & Johnson Medtech is comprised of eleven $1B platforms. The world’s second-largest medical devices business is also leading the industry in developing integrated, digitized solutions to improve outcomes for millions of people around the world.

Ashley is a member of the Johnson & Johnson Executive Committee and leads the Medtech Group Operating Committee. She also serves on the Executive Committee of AdvaMed, the leading global trade association and consortium of companies for the medical devices industry.

Ashley has more than 25 years of experience working at Johnson & Johnson. In her time leading Medtech, she has strengthened the division’s core portfolio, spearheaded the company’s entrance into telehealth, robotics, and digital surgery, and doubled the value of its pipeline to $10 billion in 2020 from 2018. Ashley also led the deployment of $10B in capital across M&A activity in recent years to bolster the portfolio. This targeted business transformation strategy ultimately accelerated performance and led to revenue growth from 1.5% in 2017 to nearly 5% in 2021. It also resulted in market share gains in a majority of Medtech’s platforms, which enjoy #1 or #2 market position today.

Ashley and the global J&J Medtech team were recently recognized by Fast Company as one of the most innovative health companies of 2022. Ashley was recently honored as one of 50 individuals named to Forbes’ inaugural CEO NEXT list and was ranked #1 on the Top 25 Women Leaders in Medical Devices list by The Healthcare Technology Report. She ranked #41 on Fortune’s Most Powerful Women List in 2019 and was named a Woman of Achievement in 2020 by the National Association of Female Executives for her dedication to advancing diversity, equity, and inclusion.

A Pennsylvania native and graduate of the University of Pennsylvania, Ashley is proud to serve on the Board of Trustees for the Children’s Hospital of Philadelphia (CHOP), where she helps guide the hospital’s mission in delivering safe, high-quality, and family-centered care. CHOP was ranked #1 on Forbes’ 2022 list of America’s Best Large Employers.

Joe Mullings has been building companies and careers since 1989. He is the Founder, Chairman and CEO of The Mullings Group, the world’s leading search firm in the medical device industry. The firm is responsible for more than 7,000 successful searches, representing more than 600 companies in the medical device industry.

His clients are multi-billion-dollar companies, as well as emerging startup companies that are bringing to market emerging technologies like surgical robotics, tele-robotics, artificial intelligence and deep learning. He is also President & CEO of Dragonfly Stories, which is the production company behind the video docuseries “TrueFuture” of which he is the host. He is also the founder of TMGPulse, a Medtech news and opinion website. He holds an engineering degree from The University of Dayton, Ohio.

Adam Mussomeli is a New York–based Principal at Deloitte, with more than 25 years of experience delivering global, highly complex supply chain transformations across industries, both in a consulting environment and while in industry positions. He leads the US Supply Chain & Networks Operations (SCNO) offering. Mussomeli’s projects have delivered hundreds of millions of dollars in income statement and balance sheet benefits to his clients and have been written up in multiple supply chain and operations publications.

Gina M. Raimondo  serves as the 40th  U.S. Secretary of Commerce  and was sworn in by Vice President Kamala Harris on March 3, 2021. As Secretary of Commerce, she is focused on a simple but vital mission — to spur good-paying jobs, empower entrepreneurs to innovate and grow, and help American workers and businesses compete.

Secretary Raimondo was formerly the 75th Governor of Rhode Island and its first woman governor. She grew up in Smithfield in a tight-knit Italian-American family, the youngest of Joseph and Josephine Raimondo’s three children. Her family history and her childhood experiences shaped her core beliefs in hard work, opportunity for all, and the importance of financial security.

Arriving from Italy at age 14, Secretary Raimondo’s grandfather learned English studying in the Providence Public Library and later lived with her family. Her mother was a homemaker, who dedicated her life to teaching her children about the importance of hard work and determination. Her father was a World War II Navy veteran from a family of butchers and became the first in his family to attend college thanks to the GI Bill. After working for 26 years in manufacturing, Joseph lost his job along with hundreds of others when the factory moved overseas, and the Raimondo family lost their sense of financial security.

As a teenager, Secretary Raimondo rode a public bus to LaSalle Academy in Providence, where she was valedictorian of her graduating class. She went on to graduate with honors from Harvard, where she was recognized as the top economics student in her class. She won a Rhodes Scholarship to Oxford University where she earned a doctorate and met her future husband Andy Moffit. She later graduated from Yale Law School. Secretary Raimondo clerked for US District Judge Kimba Wood and served as founding employee and senior vice president at Village Ventures.

To start her own business and be close to family, she returned home to Rhode Island and founded Point Judith Capital, a venture capital firm. In November 2010, Secretary Raimondo was elected to serve as General Treasurer of Rhode Island, receiving the largest number of votes of any statewide candidate. When she took office as General Treasurer, she tackled the state’s $7 billion unfunded pension liability. Secretary Raimondo was sworn into office as Governor in January 2015 and won a second term in 2018. She also served as chair of the Democratic Governors’ Association in 2019.

During her time as Governor, Secretary Raimondo kick-started the state’s economy and made record investments in infrastructure, education, and job training. She focused tirelessly on creating economic opportunities and good-paying jobs for all Rhode Islanders. Early in her administration, she launched an innovative workforce development program that develops business-led partnerships to address unique workforce challenges.

Secretary Raimondo is married to Andy Moffit and they have two children, Ceci and Tommy, and a rescue dog, Sparky.

Kirsten Tullia, J.D., MPH, joined the Advanced Medical Technology Association (AdvaMed) as Vice President, Payment and Health Care Delivery Policy in 2021 and currently serves as the Interim Department Head. Kirsten leads AdvaMed’s policy work in a number of areas, including outpatient payment, alternative payment models, and specialty-specific advocacy such as radiation therapy and end-stage renal disease.

Prior to joining AdvaMed, Kirsten was the Department Head for Health Policy at the MITRE Corporation. In this role, Kirsten provided health care policy thought leadership to CMS and HHS and assisted with policy development in support of federal health program implementation, as well as overseeing the work and technical delivery of department staff.

Kirsten received her J.D. from the American University Washington College of Law and her MPH from The Johns Hopkins University Bloomberg School of Public Health.

Scott Whitaker is President and CEO of AdvaMed, the world’s largest medical technology association. AdvaMed members make the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments, to help people live longer, healthier lives. AdvaMed members range from the largest to the smallest medical technology innovators and companies. 

As CEO of AdvaMed, Whitaker is the voice of the medical technology industry. He is widely recognized as a top health care advocate and policy expert with experience across multiple health policy sectors, having worked successfully with diverse stakeholder groups – including hospital, patient and physician groups, regulators, public and private payers, and global trade organizations – to advance medical technology innovation and timely patient access to next-generation treatments and cures. 

Prior to AdvaMed, Whitaker was chief operating officer of the Biotechnology Innovation Organization (BIO), the world’s largest trade association representing biotechnology companies, and president of the BIO International Convention, the world’s largest biotech conference. Having served as COO of BIO since 2005, Whitaker brings a deep knowledge of the medical technology innovation ecosystem, a wealth of health care advocacy expertise, and strong working relationships with patient groups and other industry stakeholders. 

Whitaker also previously served as chief of staff of the U.S. Department of Health & Human Services (HHS) – a cabinet agency with 67,000 employees and a budget of $550 billion – from 2003 to 2005. As HHS chief of staff, Whitaker managed the day-to-day operations of the department; led the department’s activities on all major policy and management issues and initiatives; and served as the top liaison to the White House on policy, management and political matters. He also served as assistant secretary for legislation at HHS from 2001 to 2003. Whitaker began his Washington career on Capitol Hill, where he worked for U.S. Senator Don Nickles (R-Okla.). 

Whitaker holds a master’s degree in government from Johns Hopkins University and a degree in political science from Palm Beach Atlantic University.